Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (10): 895-899.doi: 10.35541/cjd.20220511
• Research Reports • Previous Articles Next Articles
Wang Anqi1, Su Jing2, Zhang Long3, Jiang Yanan4, Zhang Juan4, Li Zailing4, Wang Wenhui1
Received:
2022-07-16
Revised:
2022-09-08
Online:
2022-10-15
Published:
2022-10-08
Contact:
Wang Wenhui; Li Zailing
E-mail:wwh0608@126.com; topbj163@sina.com
Supported by:
Wang Anqi, Su Jing, Zhang Long, Jiang Yanan, Zhang Juan, Li Zailing, Wang Wenhui. Analysis of skin manifestations in 50 children with inflammatory bowel disease[J]. Chinese Journal of Dermatology, 2022, 55(10): 895-899.doi:10.35541/cjd.20220511
[1] | 中华医学会儿科学分会消化学组, 中华医学会儿科学分会临床营养学组. 儿童炎症性肠病诊断和治疗专家共识[J]. 中华儿科杂志, 2019,57(7):501⁃507. doi: 10.3760/cma.j.issn.0578⁃1310.2019.07.002. |
[2] | Conrad MA, Rosh JR. Pediatric inflammatory bowel disease[J]. Pediatr Clin North Am, 2017,64(3):577⁃591. doi: 10.1016/j.pcl.2017.01.005. |
[3] | Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents[J]. JAMA Pediatr, 2015,169(11):1053⁃1060. doi: 10.1001/jamapediatrics.2015.1982. |
[4] | Hindryckx P, Novak G, Costanzo A, et al. Disease⁃related and drug⁃induced skin manifestations in inflammatory bowel disease[J]. Expert Rev Gastroenterol Hepatol, 2017,11(3):203⁃214. doi: 10.1080/17474124.2017.1283985. |
[5] | 中华医学会消化病学分会炎症性肠病学组病理分组, 叶子茵, 肖书渊, 等. 中国炎症性肠病病理诊断专家指导意见[J]. 中华炎性肠病杂志, 2021,5(1):5⁃20. doi: 10.3760/cma.j.cn101480⁃20200731⁃00086. |
[6] | Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010[J]. Inflamm Bowel Dis, 2010,16(1):112⁃124. doi: 10.1002/ibd.21048. |
[7] | Weidner J, Kern I, Manuwald U, et al. Study protocol epidemiology of inflammatory bowel disease in childhood and adolescence: a systematic review[J]. BMJ Open, 2020,10(12):e037669. doi: 10.1136/bmjopen⁃2020⁃037669. |
[8] | Turner D, Griffiths AM, Walters TD, et al. Appraisal of the pediatric Crohn′s disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties[J]. Am J Gastroenterol, 2010,105(9):2085⁃2092. doi: 10.1038/ajg.2010.143. |
[9] | Shimizu H, Ebana R, Kudo T, et al. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease[J]. J Gastroenterol, 2022,57(5):344⁃356. doi: 10.1007/s00535⁃022⁃01856⁃w. |
[10] | 赵莺, 徐锦. 粪便钙卫蛋白在儿童炎症性肠病中的临床意义[J]. 检验医学, 2022,37(5):429⁃432. doi: 10.3969/j.issn.1673⁃8640.2022.05.006. |
[11] | 笪红婷, 徐元宏. 粪便钙卫蛋白检测在肠易激综合征和炎症性肠病鉴别诊断中的意义分析[J]. 国际检验医学杂志, 2022,43(5):634⁃636. doi: 10.3969/j.issn.1673⁃4130.2022.05.026. |
[12] | Garber A, Regueiro M. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, etiopathogenesis, and management[J]. Curr Gastroenterol Rep, 2019,21(7):31. doi: 10.1007/s11894⁃019⁃0698⁃1. |
[13] | Rogler G, Singh A, Kavanaugh A, et al. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management[J]. Gastroenterology, 2021,161(4):1118⁃1132. doi: 10.1053/j.gastro. 2021.07.042. |
[14] | Iida T, Hida T, Matsuura M, et al. Current clinical issue of skin lesions in patients with inflammatory bowel disease[J]. Clin J Gastroenterol, 2019,12(6):501⁃510. doi: 10.1007/s12328⁃019⁃00958⁃y. |
[15] | Diaconescu S, Strat S, Balan GG, et al. Dermatological manifestations in pediatric inflammatory bowel disease[J]. Medicina (Kaunas), 2020,56(9):425. doi: 10.3390/medicina56 090425. |
[16] | Ickrath F, Stoevesandt J, Schulmeyer L, et al. Metastatic Crohn′s disease: an underestimated entity[J]. J Dtsch Dermatol Ges, 2021,19(7):973⁃982. doi: 10.1111/ddg.14447. |
[17] | Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends[J]. Inflamm Bowel Dis, 2011,17(1):423⁃439. doi: 10.1002/ibd.21349. |
[18] | Polcz M, Gu J, Florin T. Pyoderma gangrenosum in inflammatory bowel disease: the experience at Mater Health Services′ Adult Hospital 1998-2009[J]. J Crohns Colitis, 2011,5(2):148⁃151. doi: 10.1016/j.crohns.2010.10.006. |
[19] | Greuter T, Navarini A, Vavricka SR. Skin manifestations of inflammatory bowel disease[J]. Clin Rev Allergy Immunol, 2017,53(3):413⁃427. doi: 10.1007/s12016⁃017⁃8617⁃4. |
[20] | Alvarez⁃Payares JC, Ramírez⁃Urrea S, Correa⁃Parra L, et al. Mucocutaneous manifestations of inflammatory bowel disease[J]. Cureus, 2021,13(8):e17191. doi: 10.7759/cureus.17191. |
[21] | Suh HY, Lee WJ, Na SY. Dermatologic manifestations in inflammatory bowel disease[J]. Korean J Gastroenterol, 2019,73(5):285⁃293. doi: 10.4166/kjg.2019.73.5.285. |
[22] | Antonelli E, Bassotti G, Tramontana M, et al. Dermatological manifestations in inflammatory bowel diseases[J]. J Clin Med, 2021,10(2):364. doi: 10.3390/jcm10020364. |
[23] | Peyrin⁃Biroulet L, Van Assche G, Gómez⁃Ulloa D, et al. Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease[J]. Clin Gastroenterol Hepatol, 2017,15(1):25⁃36.e27. doi: 10. 1016/j.cgh.2016.06.025. |
[24] | Palucka AK, Blanck JP, Bennett L, et al. Cross⁃regulation of TNF and IFN⁃alpha in autoimmune diseases[J]. Proc Natl Acad Sci U S A, 2005,102(9):3372⁃3377. doi: 10.1073/pnas.04085 06102. |
[25] | Li SJ, Perez⁃Chada LM, Merola JF. TNF inhibitor⁃induced psoriasis: proposed algorithm for treatment and management[J]. J Psoriasis Psoriatic Arthritis, 2019,4(2):70⁃80. doi: 10.1177/2475530318810851. |
[26] | Ezzedine K, Visseaux L, Cadiot G, et al. Ustekinumab for skin reactions associated with anti⁃tumor necrosis factor⁃α agents in patients with inflammatory bowel diseases: a single⁃center retrospective study[J]. J Dermatol, 2019,46(4):322⁃327. doi: 10.1111/1346⁃8138.14816. |
[27] | Tillack C, Ehmann LM, Friedrich M, et al. Anti⁃TNF antibody⁃induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon⁃γ⁃expressing Th1 cells and IL⁃17A/IL⁃22⁃expressing Th17 cells and respond to anti⁃IL⁃12/IL⁃23 antibody treatment[J]. Gut, 2014,63(4):567⁃577. doi: 10.1136/gutjnl⁃2012⁃302853. |
[28] | Ho T, Orenstein LAV, Boos MD, et al. Cutaneous small⁃vessel vasculitis in two children with inflammatory bowel disease: case series and review of the literature[J]. Pediatr Dermatol, 2017, 34(5):e235⁃e240. doi: 10.1111/pde.13218. |
[1] | Gu Ankang, Zhang Yu, Ma Faku, Kong Xiangjun, Zhang Litao. Clinicopathological analysis of 56 cases of swimming pool granuloma [J]. Chinese Journal of Dermatology, 2022, 55(9): 795-798. |
[2] | Yang Zhou, Xu Zhe, Wang Zhaoyang, Chen Yunliu, Ma Lin. TP63 gene mutation analysis in a case of ankyloblepharon-ectodermal defects-cleft lip/palate syndrome [J]. Chinese Journal of Dermatology, 2022, 55(8): 696-699. |
[3] | Zhang Shimin, Hu Yunyun, Zhao Xiaoqing, Du Lianjun, Cao Hua, Zheng Jie. Application of imaging techniques in diagnosis and severity assessment of dermatomyositis [J]. Chinese Journal of Dermatology, 2022, 55(7): 637-640. |
[4] | Wang Yuan, Li Zhiliang, Li Suo, Jing Ke, Sun Chao, Liang Guirong, Zhang Hanmei, Feng Suying. Clinical and immunoserological features of 7 cases of anti-p200 pemphigoid [J]. Chinese Journal of Dermatology, 2022, 55(7): 557-561. |
[5] | Su Wei, Deng Wei, Sun Xuefeng, Zhang Sheng, Liu Xiaoyan. Clinical significance of lesion distribution in children with Sturge-Weber syndrome [J]. Chinese Journal of Dermatology, 2022, 55(5): 417-421. |
[6] | Song Xiaoting, Liu Bo, Chen Yudi, Zhao Zuotao. Pathophysiological pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2022, 55(5): 446-449. |
[7] | Liu Yan, Qiu Lin, Fu Yuexian, Tian Xiaofei, Yuan Xingang, Xiao Jun, Li Tianwu, Mao Xiaobo, Mei Ailian, Guo Yongqiang, Zhou Rong. Efficacy of surgical treatment for 35 children with nail matrix nevi [J]. Chinese Journal of Dermatology, 2022, 55(5): 430-433. |
[8] | Shen Chen, Chen Junjun, Yang Ji, Hu Dongyan, Xin Chongmei, Li Ming. Clinical features and classification of 180 patients with morphea [J]. Chinese Journal of Dermatology, 2022, 55(4): 308-315. |
[9] | Tian Jing, Liang Yuan, Shen Chunping, Zhao Mutong, Wang Yang, Wang Shan, Jiao Lei, Ma Lin. Analysis of short-term efficacy and safety of the first subcutaneous injection of dupilumab in the treatment of moderate-to-severe childhood atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 299-303. |
[10] | Wang Zhaoyang, Chen Anwei, Xiang Xin, Luo Xiaoyan, Xu Zigang, Wang Hua, Ma Lin. An investigation into the current situation of pediatric psoriasis based on the information systems from two children′s hospitals [J]. Chinese Journal of Dermatology, 2022, 55(3): 246-250. |
[11] | Han Xiaofeng, Sun Juan, Qiu Lei, Wei Li, Ma Lin. Analysis of clinical and pathological features of 29 cases of perforating pilomatricoma [J]. Chinese Journal of Dermatology, 2022, 55(3): 196-199. |
[12] | Zhong Liansheng, Chen Xiaoyi, Xiao Jing, Gao Haimei, Ji Xiuwai. Clinical analysis of 10 cases of congenital triangular alopecia [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210480-e20210480. |
[13] | Wang Jiaqi, Wang Ping, Li Liuyu, Fan Qimin, Zhu Mengyan, Wang Yanqing, Zhou Hongyu, Shen Hong, Xu Ai′e. Cutaneous hypopigmented lymphoproliferative disorders: a clinicopathological study of 41 cases [J]. Chinese Journal of Dermatology, 2022, 55(2): 110-115. |
[14] | He Rui, Zhang Bin, Li Li, Wei Li, Zhang Nan, Yu Tong, Yin Jie, Xu Zigang, Ma Lin. Clinical efficacy and safety of topical sirolimus in the treatment of 19 cases of superficial vascular malformation in children [J]. Chinese Journal of Dermatology, 2022, 55(2): 129-134. |
[15] | Li Jiafeng, Liu Ling, Liu Fang. Clinicopathological analysis of eight cases of follicular porokeratosis [J]. Chinese Journal of Dermatology, 2022, 55(10): 854-857. |
|